Abstract
Over the last decade, imaging as a detection mode for cell based assays has opened a new world of opportunities to measure “phenotypic endpoints” in both current and developing biological models. These “high content” methods combine multiple measurements of cell physiology, whether it comes from sub-cellular compartments, multicellular structures, or model organisms. The resulting multifaceted data can be used to derive new insights into complex phenomena from cell differentiation to compound pharmacology and toxicity. Exploring the major application areas through review of the growing compendium of literature provides evidence that this technology is having a tangible impact on drug discovery and the life sciences.
Keywords: High content screening, cell signaling, oncology, neurobiology, in vitro toxicology, target identification, target validation, RNAi, stem cells
Combinatorial Chemistry & High Throughput Screening
Title: Applications of High Content Screening in Life Science Research
Volume: 12 Issue: 9
Author(s): Joseph M. Zock*
Affiliation:
- Thermo Fisher Scientific, 100 Technology Dr, Pittsburgh, PA 15219, USA.,United States
Keywords: High content screening, cell signaling, oncology, neurobiology, in vitro toxicology, target identification, target validation, RNAi, stem cells
Abstract: Over the last decade, imaging as a detection mode for cell based assays has opened a new world of opportunities to measure “phenotypic endpoints” in both current and developing biological models. These “high content” methods combine multiple measurements of cell physiology, whether it comes from sub-cellular compartments, multicellular structures, or model organisms. The resulting multifaceted data can be used to derive new insights into complex phenomena from cell differentiation to compound pharmacology and toxicity. Exploring the major application areas through review of the growing compendium of literature provides evidence that this technology is having a tangible impact on drug discovery and the life sciences.
Export Options
About this article
Cite this article as:
Zock M. Joseph*, Applications of High Content Screening in Life Science Research, Combinatorial Chemistry & High Throughput Screening 2009; 12(9) . https://dx.doi.org/10.2174/138620709789383277
DOI https://dx.doi.org/10.2174/138620709789383277 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Current Enzyme Inhibition Biopolymer-based Scaffolds for Tissue Engineering Applications
Current Drug Targets Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Platinum-Based Agents for Individualized Cancer Treatment
Current Molecular Medicine Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Recent Advances in Oncological Submissions of Dendrimer
Current Pharmaceutical Design SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Current Cancer Drug Targets Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
Current Pharmaceutical Design A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry An EJC Factor RBM8a Regulates Anxiety Behaviors
Current Molecular Medicine Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development
Current Pharmaceutical Design Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line
Drug Metabolism Letters Impaired Expression and Function of Signaling Pathway Enzymes by Anthocyanins: Role on Cancer Prevention and Progression
Current Enzyme Inhibition Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design Quantum Dot-Based Nanoprobes for In Vivo Targeted Imaging
Current Molecular Medicine Targeting Cancer Cells with Photoactive Silica Nanoparticles
Current Pharmaceutical Design Editorial [ Hot Topic:Biology in Anticancer Treatment (Guest Editor: Bruno Vincenzi)]
Current Cancer Drug Targets Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design